We are happy to welcome Newormics to ACC Bioscience Incubator. Newormics is spinoff from the Femtosecond Laboratory in Dr. Ben-Yakar’s Group at the University of Texas at Austin.

Newormics is a developer of the first high-throughput, high-content drug screening platforms for use with in vivo small animal models as well as in vitro 3D tissue constructs. The company provides proprietary microfluidics-based platforms to advance early stage drug discovery and toxicity studies for faster and better drug development with cost-effective solutions.

Read more about Newormics:

Silicon Hills article

MassChallenge TX announcement

Huntingdon Disease News

Check out the video below of Newormics’ technology in action: